Immutep Ltd (IMMP) Stock Price, Quote, News & History

IMMPNASDAQ
$0.3311
-0.0422-11.3%
At close: Sep 11, 5:00 PM EST
$0.3398
-0.0335-8.97%
Pre-Market: 5:06 AM EST

Immutep (IMMP) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-
Investing Cash Flow (TTM)
56.46M
Financing Cash Flow (TTM)
-214.42K
Free Cash Flow (TTM)
-55.56M
Capital Expenditure (TTM)
-92.93K
Net Change in Cash (TTM)
783.36K

Analyst Trends and Forecast

1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.03M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
4.67
PB Ratio (TTM)
1.11
Earnings Yield % (TTM)
-116.77%
Earnings Yield % (FWD)
-60.53%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.30

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$214.42K
Total Cash
$63.67M
Debt to Equity
0.02
Issuance of Debt (TTM)
-$214.42K
Repayment of Debt (TTM)
-$214.42K

Key Statistics

Open
-
Close
$0.33
Volume / Avg.
4.66K / 294.32K
Day Range
- - -
52 Wk Range
0.29 - 3.53
Market Cap
$50.08M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
41
Short Interest
0.74%
Days to Cover
9.7

About

Sector
Health Care
Industry
Biotechnology
Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Immutep (IMMP) stock?

A

You can purchase shares of Immutep (NASDAQ:IMMP) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Immutep (IMMP) stock?

A

Immutep has a consensus price target of $7.00.

Q

What is the current price for Immutep (IMMP)?

A

The stock price for Immutep (NASDAQ: IMMP) is $0.3398 last updated September 15, 2026 at 5:06 AM EDT.

Q

Does Immutep (IMMP) pay a dividend?

A

There are no upcoming dividends for Immutep.

Q

When is Immutep (NASDAQ:IMMP) reporting earnings?

A

Immutep does not have any upcoming earnings scheduled.

Q

Is Immutep (IMMP) going to split?

A

There is no upcoming split for Immutep.

Q

What sector and industry does Immutep (IMMP) operate in?

A

Immutep is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.